223 related articles for article (PubMed ID: 25158772)
1. Predictors of mortality in patients with lacunar stroke in the secondary prevention of small subcortical strokes trial.
Sharma M; Pearce LA; Benavente OR; Anderson DC; Connolly SJ; Palacio S; Coffey CS; Hart RG
Stroke; 2014 Oct; 45(10):2989-94. PubMed ID: 25158772
[TBL] [Abstract][Full Text] [Related]
2. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.
; Benavente OR; Hart RG; McClure LA; Szychowski JM; Coffey CS; Pearce LA
N Engl J Med; 2012 Aug; 367(9):817-25. PubMed ID: 22931315
[TBL] [Abstract][Full Text] [Related]
3.
Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Benavente OR; Peralta CA
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1040-1047. PubMed ID: 28446537
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
Pearce LA; McClure LA; Anderson DC; Jacova C; Sharma M; Hart RG; Benavente OR;
Lancet Neurol; 2014 Dec; 13(12):1177-85. PubMed ID: 25453457
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study.
Elkind MS; Luna JM; McClure LA; Zhang Y; Coffey CS; Roldan A; Del Brutto OH; Pretell EJ; Pettigrew LC; Meyer BC; Tapia J; White C; Benavente OR;
Stroke; 2014 Mar; 45(3):707-16. PubMed ID: 24523037
[TBL] [Abstract][Full Text] [Related]
6. ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection?
Côté R; Zhang Y; Hart RG; McClure LA; Anderson DC; Talbert RL; Benavente OR
Neurology; 2014 Feb; 82(5):382-9. PubMed ID: 24384643
[TBL] [Abstract][Full Text] [Related]
7. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y; Kimura K; Otsuka T; Toyoda K; Uchiyama S; Hoshino H; Sakai N; Okada Y; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2023 Mar; 54(3):697-705. PubMed ID: 36734235
[TBL] [Abstract][Full Text] [Related]
8. Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
Agarwal A; Cheung AK; Ma J; Cho M; Li M
J Am Heart Assoc; 2019 Aug; 8(16):e013098. PubMed ID: 31423869
[TBL] [Abstract][Full Text] [Related]
9. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.
Peralta CA; McClure LA; Scherzer R; Odden MC; White CL; Shlipak M; Benavente O; Pergola P
Circulation; 2016 Feb; 133(6):584-91. PubMed ID: 26762524
[TBL] [Abstract][Full Text] [Related]
10. Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
Shoamanesh A; Pearce LA; Bazan C; Catanese L; McClure LA; Sharma M; Marti-Fabregas J; Anderson DC; Kase CS; Hart RG; Benavente OR;
Ann Neurol; 2017 Aug; 82(2):196-207. PubMed ID: 28681535
[TBL] [Abstract][Full Text] [Related]
11. Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).
Zhou Y; Pan Y; Wu Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Wang C; Meng X; Wang Y; Wang Y;
Stroke; 2016 Nov; 47(11):2791-2796. PubMed ID: 27738237
[TBL] [Abstract][Full Text] [Related]
12. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
Li Z; Wang Y; Zhao X; Liu L; Wang D; Wang C; Meng X; Li H; Pan Y; Wang X; Wang C; Yang X; Zhang C; Jing J; Xian Y; Johnston SC; Wang Y;
J Am Heart Assoc; 2016 Mar; 5(3):e003038. PubMed ID: 27001965
[TBL] [Abstract][Full Text] [Related]
13. Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial.
Odden MC; McClure LA; Sawaya BP; White CL; Peralta CA; Field TS; Hart RG; Benavente OR; Pergola PE
Hypertension; 2016 Jan; 67(1):63-9. PubMed ID: 26553236
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.
White CL; Szychowski JM; Roldan A; Benavente MF; Pretell EJ; Del Brutto OH; Kase CS; Arauz A; Meyer BC; Meissner I; Demaerschalk BM; McClure LA; Coffey CS; Pearce LA; Conwit R; Irby LH; Peri K; Pergola PE; Hart RG; Benavente OR;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):764-74. PubMed ID: 22516427
[TBL] [Abstract][Full Text] [Related]
15. Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials.
Palacio S; Hart RG; Pearce LA; Benavente OR
Stroke; 2012 Aug; 43(8):2157-62. PubMed ID: 22826359
[TBL] [Abstract][Full Text] [Related]
16. CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.
McDonough CW; McClure LA; Mitchell BD; Gong Y; Horenstein RB; Lewis JP; Field TS; Talbert RL; Benavente OR; Johnson JA; Shuldiner AR
J Am Heart Assoc; 2015 May; 4(6):e001652. PubMed ID: 26019129
[TBL] [Abstract][Full Text] [Related]
17. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Berger PB; Bhatt DL; Fuster V; Steg PG; Fox KA; Shao M; Brennan DM; Hacke W; Montalescot G; Steinhubl SR; Topol EJ;
Circulation; 2010 Jun; 121(23):2575-83. PubMed ID: 20516378
[TBL] [Abstract][Full Text] [Related]
18. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY;
N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750
[TBL] [Abstract][Full Text] [Related]
20. Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial.
Field TS; Pearce LA; Asinger RW; Smyth NG; De SK; Hart RG; Benavente OR;
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1423-9. PubMed ID: 25840952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
